Clinical trial · Observational
Breath Gas Analysis for the Diagnosis of Breast Cancer
Leistungsbewertungsprüfung: Atemluftanalyse für Die Diagnose Von Brustkrebs, für Die Überwachung Der Therapie Und für Die Voraussage Des Metastasenrisikos
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Sponsor quit partnership in Oncotyrol-Center for Personalized Medicine, and consequential loss of public funding.
Summary
Brief summary (as posted)
The volatile content of the exhaled breath gas of mamma carcinoma patients will be chemically analyzed by proton-transfer-reaction time of flight mass spectrometry. The goal of the study is to determine typical breath gas components that allow to distinguish patients with mamma carcinoma from women without carcinoma. Further, the investigators will test whether these breath gas markers can be used as tumor markers, which change in a typical manner during the progress of the disease. Finally the data will be investigated for the presence of marker components, that identify patients who will develop metastasis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Mamma Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Breath Collecting Unit | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Mamma Carcinoma, no treatment
- interventionNames
- Device: Breath Collecting Unit
- label
- Mamma Carcinoma, treatment
- interventionNames
- Device: Breath Collecting Unit
- label
- No Mamma Carcinoma diagnosed by X-ray
- interventionNames
- Device: Breath Collecting Unit
Primary outcomes (1)
- measure
- Breath gas markers
- timeFrame
- 3 years
- description
- Breath gas markers that allow to distinguish patients with mamma carcinoma from women without carcinoma;
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Mamma carcinoma diagnosed by histology (cases) * Mamma carcinoma excluded by radiology (controls) * At the time of diagnosis before surgery * At the beginning and during chemotherapy; Exclusion Criteria: * No informed consent form singed
References
Publications (0)
Data not yet available